Our Colloborations


HK Pharmaceuticals is seeking to partner with pharmaceutical and biotechnology companies to understand and eliminate undesired side effects which could prohibit a drug from reaching its full commercial potential – either due to withdrawal from the market or failure in late stage clinical trials.

HK Pharmaceuticals’ CCMS™ technology can be incorporated early in the drug development process, leading to a better understanding of structure-function relationships and mechanism of action and indicating that certain drug candidates should be abandoned early in the process before large investments have been made.

To discuss partnership opportunties, please contact Daniel Little, Ph.D., President, dlittle@hkpharma.com.